| CGEM Average Annual Return Chart Since 2021 | |||
Also see: • CGEM stock yearly return 2022 • CGEM stock yearly return 2023 • CGEM stock yearly return 2024 • CGEM stock yearly return 2025 • CGEM YTD return | |||
| Average Annual Return Benchmarks |
|
Compare CGEM average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| CGEM Share Performance |
| CGEM Average Annual Return Table Since 2021 | ||||||||||||||||||||||||||||||
CGEM average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| About Cullinan Therapeutics Inc |
| Cullinan Therapeutics, Inc., formerly Cullinan Oncology, Inc., is a biopharmaceutical company focused on developing modality-agnostic targeted therapies. It has a portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its pipeline includes CLN-619, CLN-978, Zipalertinib (CLN-081/TAS6417), CLN-049, CLN-418, and CLN-617. Its lead unpartnered program, CLN-619, is a humanized lgG1 monoclonal antibody (mAb) that binds to the stress induced ligands MICA and MICB (MICA/B), which are expressed on a variety of solid tumors and hematologic malignancies. The CGEM average annual return since 2021 is shown above.
The Average Annual Return on the CGEM average annual return since 2021 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends. Thus, researching Average Annual Returns is good practice for investors — whether CGEM average annual return since 2021 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the CGEM average annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| CGEM Current Stock Quote |
Quotes delayed 20 minutes  Free CGEM Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Average Annual Return! | |
|
| Average Annual Return Peers |
| Cullinan Therapeutics (CGEM) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
CGEN Average Annual Return CGON Average Annual Return CGTX Average Annual Return CHE Average Annual Return CHRS Average Annual Return CI Average Annual Return CING Average Annual Return CLDX Average Annual Return CLNN Average Annual Return CLOV Average Annual Return More Healthcare companies » |
Video: Don't Forget Dividends in Average Annual Return!